Carl Zeiss Meditec falls on Q4 miss, FY 2025 guidance

Carl Zeiss Meditec AG

11/12/2024 07:27

** German optical systems maker Carl Zeiss Meditec  AFXG.DE 
shares fall 9.2% in early Frankfurt trade after the firm
released its Q4 and FY 2023/2024 results, falling below
expectations
    ** Carl Zeiss Meditec reported Q4 sales of 579.6 million
euros  ($609.45 million), as well as a reported EBIT of 31.8
million euros  
    ** "Carl Zeiss Q4 sales came in 2.7% below consensus but adj
EBIT was 13.6% ahead but reported EBIT was 50% below," J.P
Morgan writes
    ** J.P Morgan adds the FY 2025 guidance which calls for
stable to slightly higher EBITA and EBITA margins implies around
low double digits cuts to consensus at the mid-point
    ** Carl Zeiss Meditec falls to the bottom of Germany's
mid-caps index  .MDAXI  in early Frankfurt trade


($1 = 0.9510 euros)

 (Reporting by Tristan Veyet)
 ((Tristan.chabba@thomsonreuters.com))